Pharmaceutical giant GlaxoSmithkline is using software from Spotfire to help researchers gather and understand multiple sources of information.
Spotfire is a provider of interactive analytics software designed to help end-users discover new insights in information. Its Spotfire DecisionSite product is being deployed across the GSK Chemistry Domain area to assist the discovery and development of new products and processes.
The software is being used by GSK’s Chemistry Domain to work with the increasingly large volume of high throughput data coming from its screening programme. GSK’s Chemistry Domain has worked closely with Spotfire’s professional services team to develop custom analytic solutions to meet some of the specific research analytic challenges.
Others users of Spotfire include Unilver, Yakult, Johnson & Johnson , Merck, Pfizer, BP and ABN Amro.
Vote for your IT greats
Who have been the most influential people in IT in the past 40 years? The greatest organisations? The best hardware and software technologies? As part of Computer Weekly’s 40th anniversary celebrations, we are asking our readers who and what has really made a difference?
Vote now at: www.computerweekly.com/ITgreats
Read more on Business applications
IR35 private sector reforms: GSK gives contractors 'quit or go PAYE' ultimatum
HMRC under fire over 'scaremongering' IR35 clampdown letters targeting GSK IT contractors
GlaxoSmithKline R&D CDO on combining Hadoop and Docker to boost drug discovery efforts
GlaxoSmithKline R&D creates data platform using Hadoop for the internal sharing of scientific data